Eli Lilly commits $15 million to fund TB drug discovery through Seattle-based initiative by Clare McGrane on November 3, 2016November 3, 2016 at 1:45 pm The Seattle-based Infectious Disease Research Institute (IDRI), a product-focused nonprofit that fights infectious diseases around the world, announced today that it will receive $15 million from pharmaceutical giant Eli Lilly to… Read More